UNSPSC 41141825: Phospholipids substrate

In this classification, this entry connotes a substrate made of Phospholipids that is used in clinical chemistry testing.

UNSPSC 41141825 Phospholipids substrate, a Commodity code, describes laboratory reagents and consumables used by state and local public health laboratories for analytical testing — specifically enzyme substrates, quality-control materials, and test kits compatible with clinical analyzers and diagnostic instruments. Recent state and local solicitations under this code show procurement of culture media for foodborne pathogen detection, whole genome sequencing reagent bundles for wastewater surveillance and variant monitoring, solid-phase extraction disks for EPA drinking-water compliance testing, gas chromatography standards and instrument components for Safe Drinking Water Act analysis, respiratory pathogen detection kits for multiplexed next-generation sequencing, and drug-testing supplies for abuse analyzer instruments. These purchases reflect the diagnostic and environmental monitoring workloads of state public health laboratories and regional county health departments.

Issuing bodies include state departments of health (Texas Health and Human Services Commission, Mississippi State Department of Health), county health departments (Gwinnett County, Georgia), and specialized research universities (University of Texas Health Science Center at San Antonio). Recent activity concentrates in Texas and Mississippi, with secondary activity in Georgia and Pennsylvania. Representative opportunities include Texas HHS Commission's IFB HHS0017881 for Biomerieux-compatible food and water testing lab supplies with responses due August 26, 2026 (historical value $25,000–$50,000); Texas HHS Commission's IFB HHS0017272 for Illumina next-generation sequencing respiratory pathogen detection kits with responses due May 19, 2026 (historical value $35,050–$90,000); Mississippi State Department of Health's sole-source procurement of Illumina whole genome sequencing kits and reagents posted April 28, 2026 with objections due May 14, 2026 (estimated cost $393,667.98); and University of Texas Health Science Center at San Antonio's RFP 745-26-P19 for comprehensive biotech research and clinical diagnostics catalog with proposals due June 4, 2026. Most procurements specify firm, fixed unit pricing, require EPA or FDA approval or compatibility certifications, and award on best-value rather than lowest-price basis.